These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1865593

  • 21. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A, Magni A, Del Puppo M, Gallus GN, Björkhem I, Federico A, Dotti MT.
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [Abstract] [Full Text] [Related]

  • 22. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.
    Catarino CB, Vollmar C, Küpper C, Seelos K, Gallenmüller C, Bartkiewicz J, Biskup S, Hörtnagel K, Klopstock T.
    J Neurol; 2018 Feb; 265(2):388-393. PubMed ID: 29260356
    [Abstract] [Full Text] [Related]

  • 23. Treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis: clinical, neurophysiological, and quantitative brain structural outcomes.
    Amador MDM, Masingue M, Debs R, Lamari F, Perlbarg V, Roze E, Degos B, Mochel F.
    J Inherit Metab Dis; 2018 Sep; 41(5):799-807. PubMed ID: 29560583
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serum bile acid profiles in cerebrotendinous xanthomatosis.
    Beppu T, Seyama Y, Kasama T, Serizawa S, Yamakawa T.
    Clin Chim Acta; 1982 Feb 05; 118(2-3):167-75. PubMed ID: 7055978
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R, Grau AJ, Schäbitz WR, Schwaninger M.
    Nervenarzt; 2002 Dec 05; 73(12):1160-6. PubMed ID: 12486565
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug 05; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study.
    Berginer VM, Berginer J, Korczyn AD, Tadmor R.
    J Neurol Sci; 1994 Mar 05; 122(1):102-8. PubMed ID: 8195796
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
    Kondo R, Wakamatsu N, Ishikawa A, Yuasa T, Miyatake T.
    Rinsho Shinkeigaku; 1991 Jun 05; 31(6):677-9. PubMed ID: 1934787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.